GSK India Reports 24 Percent PAT Growth in Q1 FY27
GSK India reported 15 percent revenue growth to INR 924 crore and a 24 percent rise in Q1 FY27 PAT to INR 253 crore, with EBITDA margin of 32 percent.
GlaxoSmithKline Pharmaceuticals | 04/08/2026 | By News Bureau
GSK Pharma to Procure Solar Power from CleanMax for its Plant at Nashik, Maharashtra
GlaxoSmithKline Pharmaceuticals (GSK Pharma) has approved a plan to procure 4.95 MWp of solar power for its Nashik plant from Clean Max Enviro Energy Solutions to increase the company’s renewable energy intake and cut down greenhouse gas emissions.
GlaxoSmithKline Pharmaceuticals | 11/11/2025 | By Mrinmoy Dey | 499
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy